Impax Investor Says Drug Price-Fixing Probe Never Disclosed
By Kali Hays ( November 14, 2016, 3:35 PM EST) -- Impax Laboratories Inc. was smacked Thursday with a shareholder suit in New Jersey federal court accusing the bioequivalent and generic drugmaker of failing to disclose to investors a U.S. Department of Justice investigation over possibly collusive market activity which has impacted the company's value....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.